Home » CSA News » Pei Wang – Award funding for “The Role of BRCA2 mutations in Pancreatic Ductal Adenocarcinoma Development”!

Pei Wang – Award funding for “The Role of BRCA2 mutations in Pancreatic Ductal Adenocarcinoma Development”!

Published On: January 27, 2025
Shared by lopesc

Congratulations to Dr. Pei Wang!

Her application entitled “The Role of BRCA2 mutations in Pancreatic Ductal Adenocarcinoma Development” to the joint CIO-MCC/PSP RFA is selected for funding. This award will be funded by the Center for Inherited Oncogenesis and the Mays Cancer Center.

 

Warm regards,

Lily Dong
Chair, CSA Department

Article Categories: CSA News